Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SUPERBRAIN + dexamethasone
- Development stage
- Unknown
- Lead developer
- Rowan
- Modality
- Small Molecules
- Administration
- Oral, Intravenous, Intramuscular, Topical, Ophthalmic
01
Overview
SUPERBRAIN + dexamethasone is a **combination drug** consisting of dexamethasone and another product or drug named SUPERBRAIN. Dexamethasone is a synthetic, fluorinated glucocorticoid widely used for its potent anti-inflammatory and immunosuppressive properties across numerous medical indications, including brain tumors, delayed encephalopathy after acute carbon monoxide poisoning, and various autoimmune, hematologic, and neoplastic conditions. It acts primarily by binding to the glucocorticoid receptor, modulating transcription, and suppressing pro-inflammatory gene networks[1][3][7]. The precise nature, mechanism, and ingredients of the product SUPERBRAIN are **unknown** based on currently available sources; there is no authoritative information on its mechanism of action, developer, or clinical application in peer-reviewed scientific literature, regulatory databases, or trusted pharmaceutical references. Therefore, information on the combination is limited to the established properties and actions of dexamethasone.
- Other names
- SUPERBRAIN
02
Targets
GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on SUPERBRAIN + dexamethasone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SUPERBRAIN + dexamethasone.